With the race to vaccinate populations against Covid-19 going full steam, health agencies such as the World Health Organization (WHO) and the Serum Institute of India...
With a new strategic platform for cell and gene therapy, Bayer aims to establish a leading position in this field while continuing to drive forward the transformation of...
A few weeks ago, Novartis said it was exploring ways to participate in the European Covid-19 vaccine manufacturing effort. In the meantime, it has been busy. On Mar. 4...
Another “Big Pharma” company with a stalled candidate of its own is stepping in to help boost national or regional Covid-19 vaccine supply. US president Joe Biden was due...
In a deal due to close in the second half of this year, privately owned French salt producer Salins is buying Nouryon’s Salt Specialties business, including brands such...
Following a decline of 2% in 2020, European chemical production is forecast to pick up by 3% in 2021, before growth rates taper off slightly in 2022, but output in that...
The US Food and Drug Administration (FDA) on 27 February granted an Emergency Use Authorization (EUA) to the Covid-19 vaccine developed by Janssen Biotech, part of US...
For mRNA vaccine maker Moderna, March is gearing up to roar in like a lion, with the tailwind setting the pace for the year ahead. Reporting 2020 financial results on Feb...
Germany’s Röhm and compatriot company OQ Chemicals have signed a Memorandum of Understanding to build a 250,000 t/y methyl methacrylate (MMA) plant in the US.
Leading US gene therapy CDMO Catalent is buying all shares of another CDMO in the same field, plasmid DNA (pDNA) specialist’s Delphi Genetics, headquartered at Gosselie...
